C.T. Fitzpatrick’s Celgene Corp CELG Stock Holding History

C.T. Fitzpatrick’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-205	Closed	-$18K	–	116
2014 Q2	$18K	Buy	+205	New	+$15.6K	﹤0.01%	97

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

C.T. Fitzpatrick's CELG Position: Q3 2014 in Review

C.T. Fitzpatrick sold out of Celgene Corp (CELG) in Q3 2014, closing a stake of 205 shares — an estimated $18K sold.

C.T. Fitzpatrick first reported a position in CELG in Q2 2014 and held it in 1 quarter. The position peaked at $18K in Q2 2014. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

C.T. Fitzpatrick reported no remaining Celgene Corp position as of Q3 2014 after selling out during the quarter.
C.T. Fitzpatrick sold 205 Celgene Corp shares in Q3 2014, an estimated $18K.
C.T. Fitzpatrick first reported a position in Celgene Corp in Q2 2014 and held it in 1 quarter.
C.T. Fitzpatrick's Celgene Corp position peaked at $18K in Q2 2014.
1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on Vulcan Value Partners's 13F filing for Q3 2014, filed 7 Nov 2014.